Table of Content

1 Anti-Infective Vaccines Market Overview
1.1 Anti-Infective Vaccines Product Overview
1.2 Anti-Infective Vaccines Market Segment by Type
1.2.1 Inactivated Vaccines
1.2.2 Conjugate Vaccines
1.2.3 Live/attenuated Vaccines
1.3 Global Anti-Infective Vaccines Market Size by Type
1.3.1 Global Anti-Infective Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Anti-Infective Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anti-Infective Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Infective Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anti-Infective Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anti-Infective Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anti-Infective Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anti-Infective Vaccines Sales Breakdown by Type (2018-2024)
2 Global Anti-Infective Vaccines Market Competition by Company
2.1 Global Top Players by Anti-Infective Vaccines Sales (2018-2024)
2.2 Global Top Players by Anti-Infective Vaccines Revenue (2018-2024)
2.3 Global Top Players by Anti-Infective Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Anti-Infective Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Infective Vaccines Market Competitive Situation and Trends
2.5.1 Anti-Infective Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Infective Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Infective Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Infective Vaccines Market
2.8 Key Manufacturers Anti-Infective Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Infective Vaccines Status and Outlook by Region
3.1 Global Anti-Infective Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Anti-Infective Vaccines Historic Market Size by Region
3.2.1 Global Anti-Infective Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Anti-Infective Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Anti-Infective Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anti-Infective Vaccines Forecasted Market Size by Region
3.3.1 Global Anti-Infective Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-Infective Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Anti-Infective Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-Infective Vaccines by Application
4.1 Anti-Infective Vaccines Market Segment by Application
4.1.1 Bacterial Diseases
4.1.2 Viral Diseases
4.2 Global Anti-Infective Vaccines Market Size by Application
4.2.1 Global Anti-Infective Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Anti-Infective Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anti-Infective Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Infective Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anti-Infective Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anti-Infective Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anti-Infective Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anti-Infective Vaccines Sales Breakdown by Application (2018-2024)
5 North America Anti-Infective Vaccines by Country
5.1 North America Anti-Infective Vaccines Historic Market Size by Country
5.1.1 North America Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Anti-Infective Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Anti-Infective Vaccines Sales in Value by Country (2018-2024)
5.2 North America Anti-Infective Vaccines Forecasted Market Size by Country
5.2.1 North America Anti-Infective Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-Infective Vaccines Sales in Value by Country (2024-2034)
6 Europe Anti-Infective Vaccines by Country
6.1 Europe Anti-Infective Vaccines Historic Market Size by Country
6.1.1 Europe Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Anti-Infective Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Anti-Infective Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Anti-Infective Vaccines Forecasted Market Size by Country
6.2.1 Europe Anti-Infective Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-Infective Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-Infective Vaccines by Region
7.1 Asia-Pacific Anti-Infective Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-Infective Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anti-Infective Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anti-Infective Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Infective Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-Infective Vaccines Sales in Value by Region (2024-2034)
8 Latin America Anti-Infective Vaccines by Country
8.1 Latin America Anti-Infective Vaccines Historic Market Size by Country
8.1.1 Latin America Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Anti-Infective Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anti-Infective Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Anti-Infective Vaccines Forecasted Market Size by Country
8.2.1 Latin America Anti-Infective Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-Infective Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-Infective Vaccines by Country
9.1 Middle East and Africa Anti-Infective Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-Infective Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anti-Infective Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anti-Infective Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Infective Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-Infective Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Emergent BioDefense Operations Lansing Inc.
10.1.1 Emergent BioDefense Operations Lansing Inc. Company Information
10.1.2 Emergent BioDefense Operations Lansing Inc. Introduction and Business Overview
10.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
10.1.5 Emergent BioDefense Operations Lansing Inc. Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi Pasteur Anti-Infective Vaccines Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 Merck & Co.
10.3.1 Merck & Co. Company Information
10.3.2 Merck & Co. Introduction and Business Overview
10.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck & Co. Anti-Infective Vaccines Products Offered
10.3.5 Merck & Co. Recent Development
10.4 MedImmune LLC
10.4.1 MedImmune LLC Company Information
10.4.2 MedImmune LLC Introduction and Business Overview
10.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 MedImmune LLC Anti-Infective Vaccines Products Offered
10.4.5 MedImmune LLC Recent Development
10.5 Novartis Vaccines
10.5.1 Novartis Vaccines Company Information
10.5.2 Novartis Vaccines Introduction and Business Overview
10.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novartis Vaccines Anti-Infective Vaccines Products Offered
10.5.5 Novartis Vaccines Recent Development
10.6 Diagnostics Ltd.
10.6.1 Diagnostics Ltd. Company Information
10.6.2 Diagnostics Ltd. Introduction and Business Overview
10.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Diagnostics Ltd. Anti-Infective Vaccines Products Offered
10.6.5 Diagnostics Ltd. Recent Development
10.7 Intercell Biomedical
10.7.1 Intercell Biomedical Company Information
10.7.2 Intercell Biomedical Introduction and Business Overview
10.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Intercell Biomedical Anti-Infective Vaccines Products Offered
10.7.5 Intercell Biomedical Recent Development
10.8 MassBiologics
10.8.1 MassBiologics Company Information
10.8.2 MassBiologics Introduction and Business Overview
10.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 MassBiologics Anti-Infective Vaccines Products Offered
10.8.5 MassBiologics Recent Development
10.9 Barr Labs, Inc.
10.9.1 Barr Labs, Inc. Company Information
10.9.2 Barr Labs, Inc. Introduction and Business Overview
10.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Barr Labs, Inc. Anti-Infective Vaccines Products Offered
10.9.5 Barr Labs, Inc. Recent Development
10.10 Organon Teknika Co.
10.10.1 Organon Teknika Co. Company Information
10.10.2 Organon Teknika Co. Introduction and Business Overview
10.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Organon Teknika Co. Anti-Infective Vaccines Products Offered
10.10.5 Organon Teknika Co. Recent Development
10.11 GlaxoSmithKline Biologicals
10.11.1 GlaxoSmithKline Biologicals Company Information
10.11.2 GlaxoSmithKline Biologicals Introduction and Business Overview
10.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Products Offered
10.11.5 GlaxoSmithKline Biologicals Recent Development
10.12 CSL Ltd.
10.12.1 CSL Ltd. Company Information
10.12.2 CSL Ltd. Introduction and Business Overview
10.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 CSL Ltd. Anti-Infective Vaccines Products Offered
10.12.5 CSL Ltd. Recent Development
10.13 ID Biomedical Co.
10.13.1 ID Biomedical Co. Company Information
10.13.2 ID Biomedical Co. Introduction and Business Overview
10.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 ID Biomedical Co. Anti-Infective Vaccines Products Offered
10.13.5 ID Biomedical Co. Recent Development
10.14 Protein Sciences Co.
10.14.1 Protein Sciences Co. Company Information
10.14.2 Protein Sciences Co. Introduction and Business Overview
10.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Protein Sciences Co. Anti-Infective Vaccines Products Offered
10.14.5 Protein Sciences Co. Recent Development
10.15 Wyeth Pharmaceuticals, Inc.
10.15.1 Wyeth Pharmaceuticals, Inc. Company Information
10.15.2 Wyeth Pharmaceuticals, Inc. Introduction and Business Overview
10.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Products Offered
10.15.5 Wyeth Pharmaceuticals, Inc. Recent Development
10.16 Berna Biotech
10.16.1 Berna Biotech Company Information
10.16.2 Berna Biotech Introduction and Business Overview
10.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Berna Biotech Anti-Infective Vaccines Products Offered
10.16.5 Berna Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Infective Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Infective Vaccines Industrial Chain Analysis
11.4 Anti-Infective Vaccines Market Dynamics
11.4.1 Anti-Infective Vaccines Industry Trends
11.4.2 Anti-Infective Vaccines Market Drivers
11.4.3 Anti-Infective Vaccines Market Challenges
11.4.4 Anti-Infective Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Infective Vaccines Distributors
12.3 Anti-Infective Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Inactivated Vaccines
Table 2. Major Company of Conjugate Vaccines
Table 3. Major Company of Live/attenuated Vaccines
Table 4. Global Anti-Infective Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Anti-Infective Vaccines Sales by Type (2018-2024) & (K Units)
Table 6. Global Anti-Infective Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Anti-Infective Vaccines Sales by Type (2018-2024) & (US& Million)
Table 8. Global Anti-Infective Vaccines Market Share in Value by Type (2018-2024)
Table 9. Global Anti-Infective Vaccines Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Anti-Infective Vaccines Sales by Type (2024-2034) & (K Units)
Table 11. Global Anti-Infective Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Anti-Infective Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Anti-Infective Vaccines Sales Market Share in Value by Type (2024-2034)
Table 14. Global Anti-Infective Vaccines Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Anti-Infective Vaccines Sales by Type (2018-2024) & (K Units)
Table 16. North America Anti-Infective Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Anti-Infective Vaccines Sales (K Units) by Type (2018-2024)
Table 18. Europe Anti-Infective Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Anti-Infective Vaccines Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Anti-Infective Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Anti-Infective Vaccines Sales (K Units) by Type (2018-2024)
Table 22. Latin America Anti-Infective Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Anti-Infective Vaccines Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Anti-Infective Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Anti-Infective Vaccines Sales by Company (2018-2024) & (K Units)
Table 26. Global Anti-Infective Vaccines Sales Share by Company (2018-2024)
Table 27. Global Anti-Infective Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Anti-Infective Vaccines Revenue Share by Company (2018-2024)
Table 29. Global Market Anti-Infective Vaccines Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Anti-Infective Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Infective Vaccines as of 2022)
Table 33. Date of Key Manufacturers Enter into Anti-Infective Vaccines Market
Table 34. Key Manufacturers Anti-Infective Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Anti-Infective Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Anti-Infective Vaccines Sales by Region (2018-2024) & (K Units)
Table 38. Global Anti-Infective Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Anti-Infective Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Anti-Infective Vaccines Sales Market Share in Value by Region (2018-2024)
Table 41. Global Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Anti-Infective Vaccines Sales by Region (2024-2034) & (K Units)
Table 43. Global Anti-Infective Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Anti-Infective Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Anti-Infective Vaccines Sales Market Share in Value by Region (2024-2034)
Table 46. Global Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Anti-Infective Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Anti-Infective Vaccines Sales by Application (2018-2024) & (K Units)
Table 49. Global Anti-Infective Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Anti-Infective Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Anti-Infective Vaccines Sales Market Share in Value by Application (2018-2024)
Table 52. Global Anti-Infective Vaccines Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Anti-Infective Vaccines Sales by Application (2024-2034) & (K Units)
Table 54. Global Anti-Infective Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Anti-Infective Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Anti-Infective Vaccines Sales Market Share in Value by Application (2024-2034)
Table 57. Global Anti-Infective Vaccines Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Anti-Infective Vaccines Sales by Application (2018-2024) (K Units)
Table 59. North America Anti-Infective Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Anti-Infective Vaccines Sales by Application (2018-2024) (K Units)
Table 61. Europe Anti-Infective Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Anti-Infective Vaccines Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Anti-Infective Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Anti-Infective Vaccines Sales by Application (2018-2024) (K Units)
Table 65. Latin America Anti-Infective Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Anti-Infective Vaccines Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Anti-Infective Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Anti-Infective Vaccines Sales by Country (2018-2024) & (K Units)
Table 69. North America Anti-Infective Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Anti-Infective Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Anti-Infective Vaccines Sales Market Share in Value by Country (2018-2024)
Table 72. North America Anti-Infective Vaccines Sales by Country (2024-2034) & (K Units)
Table 73. North America Anti-Infective Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Anti-Infective Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Anti-Infective Vaccines Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Anti-Infective Vaccines Sales by Country (2018-2024) & (K Units)
Table 77. Europe Anti-Infective Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Anti-Infective Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Anti-Infective Vaccines Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Anti-Infective Vaccines Sales by Country (2024-2034) & (K Units)
Table 81. Europe Anti-Infective Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Anti-Infective Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Anti-Infective Vaccines Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Anti-Infective Vaccines Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Anti-Infective Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Anti-Infective Vaccines Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Anti-Infective Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Anti-Infective Vaccines Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Anti-Infective Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Anti-Infective Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Anti-Infective Vaccines Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Anti-Infective Vaccines Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Anti-Infective Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Anti-Infective Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Anti-Infective Vaccines Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Anti-Infective Vaccines Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Anti-Infective Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Anti-Infective Vaccines Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Anti-Infective Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Value by Country (2024-2034)
Table 108. Emergent BioDefense Operations Lansing Inc. Company Information
Table 109. Emergent BioDefense Operations Lansing Inc. Introduction and Business Overview
Table 110. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product
Table 112. Emergent BioDefense Operations Lansing Inc. Recent Development
Table 113. Sanofi Pasteur Company Information
Table 114. Sanofi Pasteur Introduction and Business Overview
Table 115. Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Sanofi Pasteur Anti-Infective Vaccines Product
Table 117. Sanofi Pasteur Recent Development
Table 118. Merck & Co. Company Information
Table 119. Merck & Co. Introduction and Business Overview
Table 120. Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Merck & Co. Anti-Infective Vaccines Product
Table 122. Merck & Co. Recent Development
Table 123. MedImmune LLC Company Information
Table 124. MedImmune LLC Introduction and Business Overview
Table 125. MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. MedImmune LLC Anti-Infective Vaccines Product
Table 127. MedImmune LLC Recent Development
Table 128. Novartis Vaccines Company Information
Table 129. Novartis Vaccines Introduction and Business Overview
Table 130. Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Novartis Vaccines Anti-Infective Vaccines Product
Table 132. Novartis Vaccines Recent Development
Table 133. Diagnostics Ltd. Company Information
Table 134. Diagnostics Ltd. Introduction and Business Overview
Table 135. Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Diagnostics Ltd. Anti-Infective Vaccines Product
Table 137. Diagnostics Ltd. Recent Development
Table 138. Intercell Biomedical Company Information
Table 139. Intercell Biomedical Introduction and Business Overview
Table 140. Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Intercell Biomedical Anti-Infective Vaccines Product
Table 142. Intercell Biomedical Recent Development
Table 143. MassBiologics Company Information
Table 144. MassBiologics Introduction and Business Overview
Table 145. MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. MassBiologics Anti-Infective Vaccines Product
Table 147. MassBiologics Recent Development
Table 148. Barr Labs, Inc. Company Information
Table 149. Barr Labs, Inc. Introduction and Business Overview
Table 150. Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Barr Labs, Inc. Anti-Infective Vaccines Product
Table 152. Barr Labs, Inc. Recent Development
Table 153. Organon Teknika Co. Company Information
Table 154. Organon Teknika Co. Introduction and Business Overview
Table 155. Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Organon Teknika Co. Anti-Infective Vaccines Product
Table 157. Organon Teknika Co. Recent Development
Table 158. GlaxoSmithKline Biologicals Company Information
Table 159. GlaxoSmithKline Biologicals Introduction and Business Overview
Table 160. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product
Table 162. GlaxoSmithKline Biologicals Recent Development
Table 163. CSL Ltd. Company Information
Table 164. CSL Ltd. Introduction and Business Overview
Table 165. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. CSL Ltd. Anti-Infective Vaccines Product
Table 167. CSL Ltd. Recent Development
Table 168. ID Biomedical Co. Company Information
Table 169. ID Biomedical Co. Introduction and Business Overview
Table 170. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. ID Biomedical Co. Anti-Infective Vaccines Product
Table 172. ID Biomedical Co. Recent Development
Table 173. Protein Sciences Co. Company Information
Table 174. Protein Sciences Co. Introduction and Business Overview
Table 175. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Protein Sciences Co. Anti-Infective Vaccines Product
Table 177. Protein Sciences Co. Recent Development
Table 178. Wyeth Pharmaceuticals, Inc. Company Information
Table 179. Wyeth Pharmaceuticals, Inc. Introduction and Business Overview
Table 180. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product
Table 182. Wyeth Pharmaceuticals, Inc. Recent Development
Table 183. Berna Biotech Company Information
Table 184. Berna Biotech Introduction and Business Overview
Table 185. Berna Biotech Anti-Infective Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. Berna Biotech Anti-Infective Vaccines Product
Table 187. Berna Biotech Recent Development
Table 188. Key Raw Materials Lists
Table 189. Raw Materials Key Suppliers Lists
Table 190. Anti-Infective Vaccines Market Trends
Table 191. Anti-Infective Vaccines Market Drivers
Table 192. Anti-Infective Vaccines Market Challenges
Table 193. Anti-Infective Vaccines Market Restraints
Table 194. Anti-Infective Vaccines Distributors List
Table 195. Anti-Infective Vaccines Downstream Customers
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Infective Vaccines Product Picture
Figure 2. Global Anti-Infective Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-Infective Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Anti-Infective Vaccines Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Inactivated Vaccines
Figure 6. Global Inactivated Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Conjugate Vaccines
Figure 8. Global Conjugate Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Live/attenuated Vaccines
Figure 10. Global Live/attenuated Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Anti-Infective Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Anti-Infective Vaccines Sales Market Share by Type in 2022 & 2034
Figure 13. North America Anti-Infective Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. North America Anti-Infective Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Europe Anti-Infective Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Europe Anti-Infective Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Latin America Anti-Infective Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Anti-Infective Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Infective Vaccines Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Infective Vaccines Revenue in 2022
Figure 25. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Bacterial Diseases
Figure 27. Global Bacterial Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Viral Diseases
Figure 29. Global Viral Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Anti-Infective Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Anti-Infective Vaccines Sales Market Share by Application in 2022 & 2034
Figure 32. North America Anti-Infective Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. North America Anti-Infective Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Europe Anti-Infective Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Europe Anti-Infective Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Latin America Anti-Infective Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Anti-Infective Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Anti-Infective Vaccines Manufacturing Cost Structure
Figure 43. Anti-Infective Vaccines Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed